Severe fever with thrombocytopenia syndrome (SFTS) treated with a novel antiviral medication, favipiravir (T-705).

ABSTRACT:

Background

Severe fever and thrombocytopenia syndrome (SFTS) is an acute illness with a high mortality (16.2-29.1%). Unfortunately, there is no specific cure or vaccine for SFTS.

Methods

In this open-label study, two patients with SFTS were treated with favipiravir, a new antiviral drug.

Results

Patients had a sustainable virologic, immunologic and symptomatic recovery.

Conclusions

Favipiravir may be a prosiming drug for the treatment of SFTS.

SUBMITTER: Song R 

PROVIDER: S-EPMC7223615 | biostudies-literature | 2020 Apr

REPOSITORIES: biostudies-literature